Corneal morphogenesis during development and diseases

Winston W-Y Kao1

  • 1Department of Ophthalmology, College of Medicine, University of Cincinnati, Cincinnati, OH 45267-0838, USA. winston.kao@uc.edu

Eye & Contact Lens
|August 21, 2010
PubMed
Abstract

Insights

Genetically modified mouse models reveal how genetic mutations cause corneal defects. These models, using doxycycline-inducible systems, allow precise control over gene expression to study developmental processes and diseases.

Area of Science:

  • Ophthalmology
  • Developmental Biology
  • Genetics

Background:

  • Corneal morphogenesis is a complex process crucial for vision.
  • Understanding genetic mutations underlying corneal diseases is essential for developing effective treatments.

Purpose of the Study:

  • To review the utility of genetically modified mouse lines in studying corneal development and disease.
  • To highlight the application of doxycycline-inducible systems for precise genetic manipulation in corneal research.

Main Methods:

  • Development of doxycycline-inducible (tet-On) mouse models using transgenesis and gene targeting.
  • Creation of driver lines (Krt12-rtTA, Kera-rtTA) for specific gene expression in corneal cells.
  • Generation of bitransgenic and triple transgenic mice to study gene function and ablation.

Main Results:

  • Overexpression of FGF7 in corneal epithelial cells induced beta-catenin nuclear translocation and hyperplasia, mimicking ocular surface squamous neoplasia.
  • Constitutive nuclear translocation of mutant beta-catenin in corneal epithelial cells led to hyperproliferation.
  • Expression of mutant beta-catenin in periocular mesenchymal cells resulted in eyelid malformation.

Conclusions:

  • Genetically modified mice are invaluable tools for investigating the pathophysiology of ocular surface defects.
  • These models facilitate the study of genetic mutations impacting corneal development and disease progression.